Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 1/2009

01.02.2009 | Original Article

Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study

verfasst von: J. H. Walter, A. Patterson, J. Till, G. T. N. Besley, G. Fleming, M. J. Henderson

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Summary

Background:

In order to test the feasibility of cord blood screening for inherited metabolic disease, a two-year cohort study of births in six obstetric units from five towns in the north of England was undertaken. These towns have a high prevalence of consanguineous marriages, largely among the immigrant Asian community. The purpose of the study was to determine whether early detection of metabolic disease was possible and whether early intervention would improve prognosis.

Methods:

Following parental consent, cord blood samples were collected at birth and analysed for acylcarnitine and amino acid profiles by tandem mass spectrometry in one of two laboratories. One laboratory used butylated derivatives, the other used underivatized samples. The same laboratories performed routine blood spot neonatal screening at 5–7 days of age on these babies. Patients with positive results were investigated and treated by a metabolic paediatrician as soon as possible.

Results:

24 983 births were examined. 12 952 samples were analysed as butyl derivatives, 12 031 samples were analysed underivatized. The following disorders were detected: medium-chain acyl-CoA dehydrogenase (MCAD) deficiency (1 case), 3-methylcrotonyl-CoA carboxylase (MCC) deficiency (2 cases), maternal carnitine transporter defect (2 cases), maternal MCC (1 case). The following disorders were diagnosed subsequently but were not detected by the cord blood screening: phenylketonuria (PKU) (1 case), maple syrup urine disease (MSUD) (2 cases), argininosuccinic aciduria (1 case), methylmalonic acidaemia (MMA) (1 case), glutaric aciduria type 2 (1 case), MCAD deficiency (2 cases), 3-hydroxy-3-methylglutaryl-CoA lyase deficiency (1 case). Comprehensive reference data for all analytes by both methods were obtained.

Conclusions:

Cord blood testing is of limited value in detecting inherited metabolic disease. The metabolites associated with most disorders examined were not elevated in cord blood. Some maternal disorders, carnitine transporter defect and 3-methlycrotonyl-CoA carboxylase deficiency, are detected. These remain of uncertain clinical significance. Comprehensive reference data have been obtained that will facilitate future interpretation of studies in cord blood.
Literatur
Zurück zum Zitat Dionisi-Vici C, Deodato F, Roschinger W, Rhead W, Wilcken B (2006) ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29(2–3): 383–389. doi:10.1007/s10545-006-0278-z.PubMedCrossRef Dionisi-Vici C, Deodato F, Roschinger W, Rhead W, Wilcken B (2006) ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis 29(2–3): 383–389. doi:10.​1007/​s10545-006-0278-z.PubMedCrossRef
Zurück zum Zitat Hutchesson AC, Bundey S, Preece MA, Hall SK, Green A (1998) A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J Med Genet 35(5): 366–370.PubMedCrossRef Hutchesson AC, Bundey S, Preece MA, Hall SK, Green A (1998) A comparison of disease and gene frequencies of inborn errors of metabolism among different ethnic groups in the West Midlands, UK. J Med Genet 35(5): 366–370.PubMedCrossRef
Zurück zum Zitat Leonard JV, Daish P, Naughten ER, Bartlett K (1984) The management and long term outcome of organic acidaemias. J Inherit Metab Dis 7(Supplement 1): 13–17.PubMedCrossRef Leonard JV, Daish P, Naughten ER, Bartlett K (1984) The management and long term outcome of organic acidaemias. J Inherit Metab Dis 7(Supplement 1): 13–17.PubMedCrossRef
Zurück zum Zitat Naughten ER, Jenkins J, Francis DE, Leonard JV (1982) Outcome of maple syrup urine disease. Arch Dis Child 57(12): 918–921.PubMedCrossRef Naughten ER, Jenkins J, Francis DE, Leonard JV (1982) Outcome of maple syrup urine disease. Arch Dis Child 57(12): 918–921.PubMedCrossRef
Zurück zum Zitat Patterson A, Pourfarzam M, Henderson MJ (2000) The utility of cord blood analysis in the diagnosis of organic acidaemias. J Inherit Metab Dis 23(Supplement 1): 84. Patterson A, Pourfarzam M, Henderson MJ (2000) The utility of cord blood analysis in the diagnosis of organic acidaemias. J Inherit Metab Dis 23(Supplement 1): 84.
Zurück zum Zitat Phillips P, Dalton RN, Besley G, et al (2005) Newborn screening for MCAD deficiency at one week of age. J Inherit Metab Dis 28(Supplement 1): 9. Phillips P, Dalton RN, Besley G, et al (2005) Newborn screening for MCAD deficiency at one week of age. J Inherit Metab Dis 28(Supplement 1): 9.
Zurück zum Zitat Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111(6 Pt 1): 1399–1406. doi:10.1542/peds.111.6.1399.PubMedCrossRef Schulze A, Lindner M, Kohlmuller D, Olgemoller K, Mayatepek E, Hoffmann GF (2003) Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 111(6 Pt 1): 1399–1406. doi:10.​1542/​peds.​111.​6.​1399.PubMedCrossRef
Zurück zum Zitat Shortland GJ, Besley G, Bonham J, et al (2006) Newborn screening for MCADD: findings from a multicentre UK prospective collaborative study. J Inherit Metab Dis 29(Supplement 1): 19. Shortland GJ, Besley G, Bonham J, et al (2006) Newborn screening for MCADD: findings from a multicentre UK prospective collaborative study. J Inherit Metab Dis 29(Supplement 1): 19.
Zurück zum Zitat Vijay S, Patterson A, Olpin S, et al (2006) Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis 29(5): 627–630. doi:10.1007/s10545-006-0376-y.PubMedCrossRef Vijay S, Patterson A, Olpin S, et al (2006) Carnitine transporter defect: diagnosis in asymptomatic adult women following analysis of acylcarnitines in their newborn infants. J Inherit Metab Dis 29(5): 627–630. doi:10.​1007/​s10545-006-0376-y.PubMedCrossRef
Metadaten
Titel
Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study
verfasst von
J. H. Walter
A. Patterson
J. Till
G. T. N. Besley
G. Fleming
M. J. Henderson
Publikationsdatum
01.02.2009
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 1/2009
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-008-1047-y

Weitere Artikel der Ausgabe 1/2009

Journal of Inherited Metabolic Disease 1/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.